BSESandu Pharmaceuticals LtdMinimalNeutral
Announced Sat, 4 Apr · 14:25 IST

Newspaper Publication: Saksham Niveshak Campaign & Demat Window

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+10.4%1-day move
₹32.42
prior close
₹32.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-0.7-0.7+0.3+10.4+16.9+11.8+12.6+14.1+17.2+42.2+29.2+29.7+28.3
Up moveDown movePending
AI summary

Sandu Pharmaceuticals filed a newspaper notice with BSE covering two SEBI-driven shareholder initiatives. The 'Second 100-Day Campaign - Saksham Niveshak' runs from April 1 to July 9, 2026, urging shareholders to complete KYC updates and claim unpaid dividends before transfer to IEPF. SEBI has also opened a Special Window from July 5, 2026 to July 4, 2027 for converting physical shares into dematerialised form. RTA: MUFG Intime India Private Limited. Pursuant to SEBI Circular dated Jan 30, 2026.

Likely market impact

Routine compliance filing. Shareholders with physical shares or unclaimed dividends should update KYC promptly and consider dematerialising holdings.